Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Terminated(2)

Detailed Status

Not yet recruiting1
Terminated1
Withdrawn1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

not_yet_recruiting125%
terminated125%
withdrawn125%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
not_yet_recruitingnot_applicable

Resting-state Imaging and Chronic Consumption of Non-Nutritive SweetenerS

NCT07183254
terminated

Gilles de la Tourette Syndrome (TS) and Seasonality

NCT04076852
completed

Post Covid-19 Quality of Life After Hospital Discharge in Patients Treated With NIV/C-PAP

NCT05408286
withdrawnnot_applicable

Intradural Percutaneous Stimulation

NCT03380104

Clinical Trials (4)

Showing 4 of 4 trials
NCT07183254Not Applicable

Resting-state Imaging and Chronic Consumption of Non-Nutritive SweetenerS

Not Yet Recruiting
NCT04076852

Gilles de la Tourette Syndrome (TS) and Seasonality

Terminated
NCT05408286

Post Covid-19 Quality of Life After Hospital Discharge in Patients Treated With NIV/C-PAP

Completed
NCT03380104Not Applicable

Intradural Percutaneous Stimulation

Withdrawn

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4